Q3 2025 Biogaia AB Earnings Call Transcript

Oct 22, 2025 / 07:30 AM GMT

Release Date Price: $10.42

Transcript

Key Points

Positve

BioGaia AB (BIOGY) reported a 7% increase in sales, with a 14% growth when excluding currency effects.
The company's EBIT margin improved significantly to 26% from 14% last year, driven by strategic investments and operational efficiencies.
Strong growth was observed in the Asia Pacific and Americas regions, with sales increasing by 17% and 10% respectively.
BioGaia AB (BIOGY) successfully launched new products, including Prudenttis Fresh Breath and BioGgay Gastrous Pure Action capsules, contributing to sales growth.
The company is expanding its direct market presence, with France showing record sales and plans to launch in Germany and Austria in early 2026.

Negative

Sales in the EMEA region decreased by 4%, primarily due to weaker performance in Eastern Europe.
The transition to direct markets in regions like France has led to temporary declines in sales as partners sell through existing inventory.
Operating expenses increased by 13% due to higher sales and marketing costs, particularly in North America.
The company's cash flow remained flat compared to the previous year, despite increased sales.
BioGaia AB (BIOGY) faces challenges with currency effects impacting overall growth figures.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

BIOGb.ST - Biogaia AB
Q3 2025 Biogaia AB Earnings Call
Oct 22, 2025 / 07:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Hi, this is Teresa Agnew, CEO of BioGaya, and Alex and I are here to present our Q3 results.

So sales were 327 million sec, which is an increase of 7%, due to higher sales in America as well as Asia Pacific, growth overall was 14% when excluding currency effects. Year-to-date, our growth is 8% excluding currency effects and 4% including currency.

Our sales in Asia Pacific for the quarter increased by 17%, in America's increased by 10%, and in EMEA decreased by 4%, primarily due to sales in Eastern Europe. We saw strong growth following increased media investments in the US and other prioritized direct markets such as Canada, the UK, and Australia. With our increased media, we've been attracting new consumers to the brand and enhancing

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.